Cancer Dx

Business Data, Corporate Office and Headquarter Address

About

Cancer Dx is Biotechnology in United States that focus on Provider business. They cover business area such as Provider, FSH genetic molecular test, melanoma cancer.

Business Type

Biotechnology

Country

United States

Founded

-

Company Focus

Provider

Website

-

Corporate Office and Headquarter Office address:

NJ
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

ProviderFSH genetic molecular testmelanoma cancer

* We use standard office opening hours in near Cancer Dx's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Cancer Dx Frequently Asked Questions

What or who is Cancer Dx?

Cancer Dx is Biotechnology business from United States that founded in - ( years old in ), Cancer Dx business is focusing on Provider.

Where is Cancer Dx headquarter and corporate office address?

Cancer Dx headquarter office and corporate office address is located in NJ United States.

Where is Cancer Dx country origins?

Cancer Dx was founded in United States.

What is Provider business focus on?

In , Cancer Dx is currently focus on Provider sector.

Provider Business Interest from Google Trend

Above is snippet of Google Trends for "Provider" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Cancer Dx, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.